Literature DB >> 26866500

Botulinum Toxin Treatment of Blepharospasm, Orofacial/Oromandibular Dystonia, and Hemifacial Spasm.

Barbara Illowsky Karp1, Katharine Alter2.   

Abstract

Blepharospasm is a focal dystonia characterized by involuntary, repetitive eye closure. Orofacial and oromandibular dystonia describe involuntary dystonic movements of orofacial and oromandibular musculature. Hemifacial spasm is characterized by repetitive synchronous contraction of facial nerve innervated muscles on one side of the face. In this article, the clinical presentation, epidemiology, and approaches to treatment are reviewed. Technical aspects of using botulinum toxin for treatment and reported outcomes are discussed. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26866500     DOI： 10.1055/s-0036-1571952

Source DB:  PubMed          Journal:  Semin Neurol        ISSN： 0271-8235            Impact factor:   3.420


  15 in total

1.  Defining differences in patient characteristics between spasmodic dysphonia and laryngeal tremor.

Authors:  Priyesh N Patel; Edmond K Kabagambe; Jennifer C Starkweather; Matthew Keller; Zaki A Ahmed; Simone C Gruber; Jordan S Akins; C Gaelyn Garrett; David O Francis
Journal:  Laryngoscope       Date:  2018-11-13       Impact factor: 3.325

Review 2.  Movement disorders of the mouth: a review of the common phenomenologies.

Authors:  C M Ghadery; L V Kalia; B S Connolly
Journal:  J Neurol       Date:  2022-07-29       Impact factor: 6.682

3.  Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia.

Authors:  Laura M Scorr; Michael R Silver; John Hanfelt; Elaine Sperin; Alan Freeman; H A Jinnah; Stewart A Factor
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

Review 4.  Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation.

Authors:  Ian O Bledsoe; Aaron C Viser; Marta San Luciano
Journal:  Neurotherapeutics       Date:  2020-10-23       Impact factor: 7.620

Review 5.  Treatment of Blepharospasm/Hemifacial Spasm.

Authors:  Kemar E Green; David Rastall; Eric Eggenberger
Journal:  Curr Treat Options Neurol       Date:  2017-09-30       Impact factor: 3.598

Review 6.  Botulinum Toxin Treatment of Movement Disorders.

Authors:  Yasaman Safarpour; Bahman Jabbari
Journal:  Curr Treat Options Neurol       Date:  2018-02-24       Impact factor: 3.598

Review 7.  The Efficacy and Safety of Botulinum Toxin Injections in Preventing Postoperative Scars and Improving Scar Quality: A Systematic Review and Meta-Analysis.

Authors:  Zhihua Qiao; Haojun Yang; Lewei Jin; Sandi Li; Xiancheng Wang
Journal:  Aesthetic Plast Surg       Date:  2021-03-05       Impact factor: 2.708

Review 8.  History of Botulinum Toxin Treatment in Movement Disorders.

Authors:  Bahman Jabbari
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2016-11-28

9.  Obstructive sleep apnea due to oromandibular dystonia and treated with botulinum toxin.

Authors:  Nancy Hsu; Caleb Hsieh; Aaron Thomas; Melisa Chang
Journal:  J Clin Sleep Med       Date:  2020-07-15       Impact factor: 4.062

Review 10.  Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins.

Authors:  Travis J W Hassell; David Charles
Journal:  Toxins (Basel)       Date:  2020-04-22       Impact factor: 4.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.